phosphatidylcholines has been researched along with sifuvirtide in 2 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (sifuvirtide) | Trials (sifuvirtide) | Recent Studies (post-2010) (sifuvirtide) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 24 | 2 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castanho, MA; Franquelim, HG; Loura, LM; Santos, NC | 1 |
| Castanho, MA; Franquelim, HG; Santos, NC; Veiga, AS; Weissmüller, G | 1 |
2 other study(ies) available for phosphatidylcholines and sifuvirtide
| Article | Year |
|---|---|
Sifuvirtide screens rigid membrane surfaces. establishment of a correlation between efficacy and membrane domain selectivity among HIV fusion inhibitor peptides.
Topics: Acrylamide; Amino Acid Sequence; Enfuvirtide; Fluorescence Resonance Energy Transfer; HIV Envelope Protein gp41; HIV Fusion Inhibitors; Lipid Bilayers; Membrane Fluidity; Membrane Lipids; Molecular Sequence Data; Peptide Fragments; Peptides; Phosphatidylcholines; Phosphatidylglycerols; Solutions; Water | 2008 |
Unravelling the molecular basis of the selectivity of the HIV-1 fusion inhibitor sifuvirtide towards phosphatidylcholine-rich rigid membranes.
Topics: Anti-Retroviral Agents; HIV-1; Membranes, Artificial; Peptides; Phosphatidylcholines; Virus Internalization | 2010 |